EICHORCondition: Binge Eating Disorder · Sponsor: Shire
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
To evaluate the safety and tolerability of SPD489 administered as a daily morning dose (50 or 70mg) in the treatment of moderate to severe binge eating disorder (BED) in adults
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion criteria: 1. Completion of an antecedent SPD489 BED Double-blind Study 2. Subject meets the following Diagnostic and Statistical Manual of Mental Disorders Fourth Edition - Text Revision (DSM-IV-TR) criteria for a diagnosis of BED 3. Subject has a body mass index (BMI) of \> or =18 and \< or =45 Exclusion criteria: 1. Subject has concurrent symptoms of bulimia nervosa or anorexia nervosa. 2. Subject is considered a suicide risk or risk to harm others
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Birmingham Research Group | Birmingham, Alabama, United States | — |
| Radiant Research | Tucson, Arizona, United States | — |
| Clinical Study Centers, LLC | Little Rock, Arkansas, United States | — |
| Southwestern Research, Inc. | Beverly Hills, California, United States | — |
| TRIMED Clinical Trials | Corona, California, United States | — |
| Pharmacology Research Institute | Encino, California, United States | — |
| Scripps Clinical Research Services | La Jolla, California, United States | — |
| Pharmacology Research Institute | Los Alamitos, California, United States | — |
| Pharmacology Research Institute | Newport Beach, California, United States | — |
| Pacific Research Partners, LLC | Oakland, California, United States | — |
| Excell Research, Inc | Oceanside, California, United States | — |
| PCSD - Feighner Research | San Diego, California, United States | — |
+ 77 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01657019